Back

Aggressive combined pharmacotherapy for heart failure reduces new onset atrial fibrillation

29 August 2022 (08:15 - 09:00)
Organised by:
Congress Presentation Part of: Chronic heart failure and atrial fibrillation Pharmacotherapy ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Masaki Tokutome

Fukuoka Red Cross Hospital, Fukuoka (Japan)

6 More presentations in this session

Presentation thumbnail
Type III collagen formation is significantly associated with risk of outcome in HFpEF patients but loses its significant association with underlying AF
Ms E. Angeli (Copenhagen, DK)
Abstract Slides
Presentation thumbnail
Baseline profile and results of atrial fibrillation ablation in patients with arrhythmia-induced cardiomyopathy
Ms T. Gonzalez Ferrero (Madrid, ES)
Abstract Slides
Presentation thumbnail
Association of beta blocker use with new-onset heart failure and mortality in atrial fibrillation without pre-existing heart failure: the Fushimi AF registry
Doctor M. Akao (Kyoto, JP) Doctor M. Iguchi (Kyoto, JP)
Abstract Slides
Presentation thumbnail
ABC adherence and impact of optimal medical therapy in heart failure patients with atrial fibrillation
Doctor N. Bonini (Modena, IT)
Abstract Slides
Presentation thumbnail
Survival among people with heart failure and atrial fibrillation; a population cohort study
Doctor N. Jones (Oxford, GB)
Abstract Slides

Access the full session

Session thumbnail
Chronic heart failure and atrial fibrillation

The Event

Event poster

ESC Congress 2022

29 August 2022 08:15 CET
You may be interested in
thumbnail
Congress Session
Guideline-directed medical therapy implementation in special clinical scenarios
thumbnail
Congress Presentation
Audience Q&A
thumbnail
Congress Session
Meet the Experts: summation of the science - treatment of chronic heart failure in 2023

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources